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OBJECTIVES: The WHO repeatedly stresses the importance of human capital and 
investing in health as a determinant of future economic growth. We describe a health 
care investment model that reﬂ ects the government perspective attributed to investing 
in rotavirus vaccination in Egypt, and how changes in morbidity and mortality inﬂ u-
ence government expenditure (education, health, allowances) over many generations. 
METHODS: The model applies a generational accounting approach for estimating 
the inter-temporal ﬁ scal impact of policy changes. It accounts for direct ﬁ scal transfers 
between age cohorts and the State during different life stages—childhood, school-age, 
working-age, and retirement—while simultaneously accounting for rotavirus medical 
costs, and how rotavirus mortality and morbidity inﬂ uence government ﬁ scal trans-
fers. Costs are expressed in Egyptian Pounds (EGP; 1c = 7EGP). The model is con-
structed using Egyptian life tables, rotavirus related and unrelated health care costs, 
employment earnings adjusted for age and social parameters. The model compares 
vaccinated and unvaccinated cohorts against rotavirus using discounted net tax rev-
enues (gross taxes—transfers). RESULTS: Based on variations in rotavirus vaccine 
price, the model predicts health service savings mostly attributable to averting rotavi-
rus treatment costs that could be achieved within 3–5 years and reaching EGP178 
million obtained at year-5. The discounted net tax revenue between vaccinated and 
unvaccinated cohorts was EGP5.2 billion and EGP27.3 billion at year 25 and 50, 
respectively. Investing in rotavirus vaccination represented a 15% rate of return for 
government at year-50. Long-term government net tax revenues were insensitive to 
vaccine prices, although sensitive in short-term. CONCLUSIONS: Health investment 
models are complementary to conventional economic evaluations of health care tech-
nologies. But they illuminate how government accounts, tax revenues, and expendi-
tures are inﬂ uenced by investing in health care programs. Investing in rotavirus 
vaccination could deliver early cost-offsets associated with reduced health care expen-
diture. It could increase future government net tax revenue attributed to lives saved.
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BACKGROUND: Are we witnessing the beginning of the development of a new sub-
discipline of health economics? The purpose of the paper is to outline the main theo-
retical arguments for the establishment of a new research tradition on “public health 
economics” combining public economics with health economics. METHODS: The 
results from a systematic literature search in PubMed and NHSEED on the term 
“public health economics” were presented and discussed at a workshop at the Danish 
public health conference in Nyborg September 22, 2009. Among the invited partici-
pants were health economists, public health researchers, HTA-advisors, econometri-
cians, and decision makers. RESULTS: Three main theoretical arguments were 
identiﬁ ed: 1) There is a need for developing new methods for the economic evaluation 
of public health interventions. 2) Economic evaluation of health care may be seriously 
misleading if public health research is ignored. 3) The entire health economic research 
tradition may beneﬁ t from encompassing a more socioeconomic model of health. 
CONCLUSIONS: There is limited tradition yet for health economists and researches 
within public health to work together and meet regularly, no scientiﬁ c journal speciﬁ -
cally oriented towards public health economics, and no textbook in health economics 
that include research from all these related areas. Thus, the research environment is 
to some extent characterised by lack of cooperation, which may constitute an obstacle 
for the development of a consistent and coherent line of economic research in the ﬁ eld 
of public health.
PIH60
ESTIMATING THE CROSS-SECTIONAL NUMBER AND GESTATIONAL 
AGE AT BIRTH DISTRIBUTION OF INFANTS FOR ECONOMIC AND 
HEALTH IMPACT ANALYSIS
Myers ER1, Misurski DA2, Swamy GK1
1Duke University, Durham, NC, USA; 2GlaxoSmithKline, Philadelphia, PA, USA
OBJECTIVES: In order to estimate the size of the population of infants at risk for 
seasonal inﬂ uenza because of ineligibility for vaccination, we developed a method for 
estimating the cross-sectional number of infants under 6 months of age at any point 
in time. METHODS: Data on the monthly number of deliveries at gestational ages 
23–42 weeks for 2006 (the most recent available) from from publicly accessible birth 
certiﬁ cate data from the US National Center for Health Statistics (NCHS) were used.
The number of deliveries at each gestational age each calendar week were derived 
based on the number of days in each month. Conditional probabilities for survival for 
each week after birth were derived from the linked birth and death certiﬁ cate data set 
from 2006 for each gestational age. The number of infants younger than 6 months 
with a given gestational age at birth at any point in time was calculated using the 
following formula: Number of infants (gestational age) born (current week) + Number 
of infants (gestational age) born (current week-1)*1 week survival (gestational age) 
+ . . . Number of infants (gestational age) born (current week-25)*26 week survival 
These results were then summed for gestational ages 23–42 weeks to obtain the total 
number of infants. Separate calculations were performed for single pregnancies, twins, 
and higher order multiples. RESULTS: In 2006, the average number of infants 0–6 
months of age in any given week was 1.98 million, with seasonal variation reﬂ ecting 
seasonal variability in deliveries. CONCLUSIONS: Estimates of the number of infants 
within a given age range alive at a given point in time can be derived from routinely 
collected administrative data. These estimates, together with estimates of the number 
of pregnant women, can be used for evaluation of interventions targeting pregnant 
women and infants.
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OBJECTIVES: Develop a mathematical model simulating the clinical and economic 
impact of different cervical cancer screening options for German females alongside 
HPV vaccination. METHODS: We developed a discrete event simulation (DES) 
model, describing the natural history of cervical cancer and genital warts for ﬁ ve 
categories of HPV types (HPV 16, 18, 6/11, other high risk and other low risk). To 
ﬁ t German epidemiological data, we manually calibrated model parameters for natural 
history to match a number of calibration targets including genital warts incidence by 
age, cervical cancer incidence and mortality by age, prevalence of HPV type by age, 
and distribution of HPV types by disease stage. The model also calibrates against 
prevalence of CIN by age as reported in previous HPV disease models. The ﬁ t of model 
outputs to calibration targets was represented by a calibration score computed using 
normalized residuals weighted by the quality of the available data (e.g., prioritizing 
epidemiological data over model results). Our model employs lognormal distributions 
for time to progression and two-piece exponential distributions for time to regression, 
enabling us to simulate the long separation in peak times between HPV infection, 
cervical cancer precursors and cancer incidence. RESULTS: Predicted type-speciﬁ c 
HPV-prevalence and disease incidence are close to epidemiological data. HPV preva-
lence differed from reported prevalence by <1.55% for each 5 year age group for HPV 
16, 18, and other high risk HPV. The model predicted genital warts incidence of 159 
per 100,000 (target: 167), cervical cancer incidence of 17.7 per 100,000 (target: 15.5), 
cervical cancer mortality incidence of 4.3 per 100,000 (target: 4.1), and agreed well 
with incidence age distributions. CONCLUSIONS: We developed an individual-based, 
fully calibrated model that is ready for cost-effectiveness analysis of cervical cancer 
vaccination and screening strategies. Time-to-event distributions, an inherent feature 
of DES, facilitate realistic modelling of disease progression.
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OBJECTIVE: To develop a method for estimating the cross-sectional number of 
pregnant women, distributed by gestational age for cost-effectiveness and budget 
impact analysis. METHODS: We obtained data on the monthly number of deliveries 
at gestational ages 20–42 weeks for years 2003 through 2006 (the most recent avail-
able) from publicly accessible birth certiﬁ cate data from the US National Center for 
Health Statistics (NCHS). Estimates of the number of deliveries at each gestational 
age each week were derived based on the number of days in each month, under the 
assumption that deliveries were randomly distributed throughout the month. Cohorts 
of women who became pregnant during the same calendar week were constructed 
using the following formula: Deliveries at 20 weeks (calendar week X) + Deliveries at 
21 weeks (calendar week X+1) +. . . . Deliveries at 42 weeks (calendar week X+22). 
This procedure was repeated for each week from January 2003 through July 2006. 
Estimates of the number of pregnancies between 6 and 20 weeks were generated by 
applying gestational age-speciﬁ c loss rates from a large prospective cohort study of 
early pregnancy. RESULTS: Over the 3.5 year period, there were approximately 2.5 
million pregnant women ranging from 6 to 42 weeks gestational age in the US; the 
mean weekly number increased from 2.5 to 2.6 between 2003 and 2006. There was 
also substantial seasonal variation in singleton pregnancies, with the highest number 
of pregnant women observed in March and April of each year, but no seasonal varia-
tion in multiple gestations. CONCLUSIONS: Routinely collected data on births allows 
estimation of the number of pregnant women at any point in time. Such data, in 
conjunction with estimates of probabilities of delivery and pregnancy and neonatal 
complications, can be useful for cost-effectiveness and budget impact analyses of 
interventions during pregnancy.
